Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03321643
Brief Title: Atezolizumab, Gemcitabine, Oxaliplatin, and Rituximab in Treating Patients With Relapsed or Refractory Transformed Diffuse Large B-Cell Lymphoma

First Submitted : October 25, 2017
First Submitted that Met QC Criteria : October 25, 2017
First Posted : October 26, 2017

Last Update Submitted that Met QC Criteria : August 12, 2019
Last Update Posted : August 13, 2019